Literature DB >> 14585719

Precipitation casting of polycaprolactone for applications in tissue engineering and drug delivery.

A G A Coombes1, S C Rizzi, M Williamson, J E Barralet, S Downes, W A Wallace.   

Abstract

Microporous materials have been produced by gradual precipitation from solutions of poly(epsilon-caprolactone) (PCL) in acetone induced by solvent extraction across a semi-permeable PCL membrane which is formed in situ at the polymer solution/non-solvent interface. Microparticulates of hydroxyapatite and inulin polysaccharide, respectively, were incorporated in precipitation cast PCL matrices to illustrate potential applications in hard tissue repair and macromolecular drug release. Microporous PCL and HA filled PCL materials were found to provide a favourable surface for attachment and growth of primary human osteoblasts in cell culture. The in vitro degradation characteristics of microporous PCL and inulin/PCL materials in PBS at 37 degrees C were monitored over 45 months. Microporous PCL demonstrated zero weight loss, minor changes in molecular weight characteristics and a fairly constant indentation resistance of around 1 MN/m2. Inulin-loaded PCL materials exhibited a total weight loss of approximately 17% after 12 months in PBS. The indentation resistance decreased by 50% from an initial value of 28 MN/m2 in the first 2 months and then remained stable. Precipitation cast materials based on PCL are expected to be useful for formulating long-term, controlled release devices for bioactive molecules such as growth factors and hormones and extended-residence supports for cell growth and tissue development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14585719     DOI: 10.1016/s0142-9612(03)00535-0

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  28 in total

1.  Bioresorbable Vesicles Formed through Spontaneous Self-Assembly of Amphiphilic Poly(ethylene oxide)-block-polycaprolactone.

Authors:  P Peter Ghoroghchian; Guizhi Li; Dalia H Levine; Kevin P Davis; Frank S Bates; Daniel A Hammer; Michael J Therien
Journal:  Macromolecules       Date:  2006-03-07       Impact factor: 5.985

2.  Rheological evaluations and in vitro studies of injectable bioactive glass-polycaprolactone-sodium alginate composites.

Authors:  Shokoufeh Borhan; Saeed Hesaraki; Ali-Asghar Behnamghader; Ebrahim Ghasemi
Journal:  J Mater Sci Mater Med       Date:  2016-07-18       Impact factor: 3.896

Review 3.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 4.  Application of selected scaffolds for bone tissue engineering: a systematic review.

Authors:  Sepanta Hosseinpour; Mitra Ghazizadeh Ahsaie; Maryam Rezai Rad; Mohammad Taghi Baghani; Saeed Reza Motamedian; Arash Khojasteh
Journal:  Oral Maxillofac Surg       Date:  2017-02-13

5.  Polymer-controlled release of tobramycin from bone graft void filler.

Authors:  Amanda E Brooks; Benjamin D Brooks; Sherry N Davidoff; Paul C Hogrebe; Mark A Fisher; David W Grainger
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

6.  Levofloxacin-loaded star poly(ε-caprolactone) scaffolds by additive manufacturing.

Authors:  Dario Puppi; Anna Maria Piras; Alessandro Pirosa; Stefania Sandreschi; Federica Chiellini
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

7.  Analysis of early cellular responses of anterior cruciate ligament fibroblasts seeded on different molecular weight polycaprolactone films functionalized by a bioactive poly(sodium styrene sulfonate) polymer.

Authors:  Amélie Leroux; Jagadeesh K Venkatesan; David G Castner; Magali Cucchiarini; Véronique Migonney
Journal:  Biointerphases       Date:  2019-08-12       Impact factor: 2.456

8.  Lovastatin release from polycaprolactone coated β-tricalcium phosphate: effects of pH, concentration and drug-polymer interactions.

Authors:  Solaiman Tarafder; Kelly Nansen; Susmita Bose
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-03-14       Impact factor: 7.328

9.  Physical characterization of polycaprolactone scaffolds.

Authors:  Jorge Más Estellés; Ana Vidaurre; José M Meseguer Dueñas; Isabel Castilla Cortázar
Journal:  J Mater Sci Mater Med       Date:  2007-06-28       Impact factor: 3.896

10.  In vitro and in vivo evaluation of the effects of demineralized bone matrix or calcium sulfate addition to polycaprolactone-bioglass composites.

Authors:  O Erdemli; O Captug; H Bilgili; D Orhan; A Tezcaner; D Keskin
Journal:  J Mater Sci Mater Med       Date:  2010-01       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.